Ovarial Hyperstimulation Syndrome in the Differential Diagnostics of Acute Abdomen

Czech version

Authors: A. Mikolajčík; M. Smolár; K. Biringer ¹; L. Šutiak; M. Haško ¹
Authors‘ workplace: Chirurgická klinika JLF UKo a MFN Martin, Slovenská republika, prednosta: doc. MUDr. D. Mištuna, Ph. D. ; Gynekologicko-pôrodnícka klinika JLF UKo a MFN Martin, Slovenská republika, prednosta: prof. MUDr. J. Danko, CSc. ¹
Published in: Rozhl. Chir., 2010, roč. 89, č. 7, s. 402-405.
Category: Monothematic special - Original

Overview

Introduction:
The massive world-wide development of assisted reproduction (AR) technology and marked increase of females with infertility treatment lead to different medical complications. One of them is ovarian hyperstimulatory syndrome (OHSS), potential fatal complication in AR. It demonstrates with abdominal discomfort, nauzea, vomitus, ascites, and general alteration. It can imitate an acute abdomen syndrome, and it can lead to the primary surgical assessment.

Aim:
The description of OHSS as a cause of an acute abdomen syndrome.

Methods:
Authors present a case of OHSS with the symptomatology of acute abdomen, which was handled by surgeon, primarily.

Conclusion:
Consistent patient history, including gynecological history, and careful physical and laboratory examinations with relevant imaging methods lead to the elimination of invasive procedures. OHSS is the most actual in differential diagnosis of acute abdomen in fertile females for that reasons.

Key words:
acute abdomen – assisted reproduction – ovarian hyperstimulation syndrome – OHSS

Sources

1. Jirásek, A. Náhlé příhody břišní. Praha, Melantrich, 1949, 522 s.

2. Imoedemhe, D. A. G. Prevention of ovarian hyperstimulation syndrome. Reproductive medicine in the twenty-first century. The Parthenon Publishing Group, 2002: 306–321.

3. Practice Committee of the American Society for Reproductive Medicine: Ovarian hyperstimulation syndrome. Fertility and Sterility, 2003; 80(5): 1309–1314.

4. Machač, Š., et al. Prevalence vrozených trombofilií u pacientek s těžkou formou ovariálního hyperstimulačního syndromu. Praktická gynekologie, 2007; 11(3): 77–80.

5. Hredzák, R., et al. Ovariálny hyperstimulačný syndróm. Lekárske listy, 2002; 8: 10.

6. Hredzák, R., et al. Možnosti predikcie reakcie ovárií na stimuláciu v programe IVF. Slovenská gynekológia a pôrodníctvo, 2003; 10(1): 34–35.

7. Rizk, B. Ovarian Hyperstimulation Syndrome. Epidemiology, Pathophysiology, Prevention and Management. Dostupný z WWW: <http://www.cambridge.org/catalogue/catalogue.asp?isbn=9780511217913&ss=exc>.

8. Lass, A. Monitoring of in vitro fertilization-embryo transfer cycles by ultrasound versus by ultrasound and hormonal levels: a prospective, multicenter, randomized study. Fertil. Steril., 2003; 80: 80–85.

9. Oyesanya, O. A., et al. Total ovarian volume efore human chorionic gonadotropin administrativ for ovulation induction may predict hyperstimulation syndrom. Hum. Reprod., 1995; 10: 3211–3212.

10. Maršík, L., Ďurechová, A. Ovariálny hyperstimulačný syndróm – manažment. Gynekol. prax, 2004; 3: 179–183.

11. Mathur, R., Evbuomwan, I., Jenkins, J. Prevention and management of ovarian hyperstimulation syndrome. Current Obstetrics and Gynaecology, 2002; 12: 111–116.

12. Bazzan, M., Donvito, V. Low-molecular-weight Heparin During Pregnancy. Thrombosis Research, 2001; 101: 175–186.

13. Rizk, B., Aboulghar, M. Modern management of ovarian hyperstimulation syndrome. Human Reproduction, 1991; 6(8): 1082–1087.